Cyclin-dependent kinase inhibitor 2B (CDKN2B, also known as p15) is a gene that encodes a protein that binds to CDK4 or CDK6 and inhibits their activation. Missense and silent mutations are observed in cancers such as intestinal cancer, kidney cancer, and cancers of the urinary tract. 

Related Pathways

Modified: December 4, 2015

Disclaimer: The information presented at is compiled from sources believed to be reliable. Extensive efforts have been made to make this information as accurate and as up-to-date as possible. However, the accuracy and completeness of this information cannot be guaranteed. Despite our best efforts, this information may contain typographical errors and omissions. The contents are to be used only as a guide, and health care providers should employ sound clinical judgment in interpreting this information for individual patient care.